If you need funding, whether it is to progress your research, develop a product, or enable change, below are some funding opportunities that might be of interest.
Please note that this list is not exhaustive and covers only some of the opportunities available to academics, businesses and the NHS.
Maximum funding available:
Not specified.
Competition closes:
05 January 2022
Funding overview:
The NIHR HTA Programme funds research to assess the effectiveness of technologies within the NHS. In this researcher-led workstream, grants are available for primary research and evidence synthesis on topics proposed by the researchers.
Proposals should normally evaluate the clinical and cost effectiveness of a health technology. For diagnostic technologies, researchers may suggest equivalent evaluations.
We are interested in receiving proposals addressing any health problem in areas not otherwise well covered in our portfolio. Please note that proposals should be within the scope of the HTA Programme. Proposals to investigate the organisation of health services, or services entirely outside the NHS will not be eligible. For primary research projects, which generate new data, the most suitable study design is often a randomised controlled trial, but this is not the only type of trial we fund. Other study designs may be appropriate, for instance cohort or other observational studies, or adaptive designs. All should be adequately powered and the results should be relevant across the UK population.
Learn more:
For more information or to apply for the funding opportunity, visit the NIHR website today!
Maximum funding available:
Not specified.
Competition closes:
05 January 2022
Funding overview:
The NIHR HTA Programme funds research to assess the effectiveness of technologies within the NHS. In this researcher-led workstream, grants are available for primary research and evidence synthesis on topics proposed by the researchers. Evidence synthesis projects are eligible. These should investigate clinical and cost-effectiveness. They are likely to include one or more systematic reviews and economic analysis, but other well designed studies are eligible. Researchers can also apply to the Research for Patient Benefit Programme for evidence synthesis. Researchers should justify why the HTA Programme is the most appropriate to fund this study, rather than other Programmes.
Learn more:
For more information or to apply for the funding opportunity, visit the NIHR website today!
Maximum funding available:
Not specified.
Competition closes:
05 January 2022
Funding overview:
The NIHR research programmes (EME, HTA, PHR and HS&DR) are interested in receiving applications to meet recommendations in research identified in NICE guidance, that has been published or updated since 2015. For the purposes of this call, NICE guidance includes the following: clinical, social care, public health, technology appraisals, interventional procedures and diagnostics.
Learn more:
For more information or to apply for the funding opportunity, visit the NIHR website today!
Maximum funding available:
£25,000 - £2,000,000 (25-70% costs depending on business size and location)
Competition closes:
05 January 2022
Funding overview:
UK registered organisations can apply for a share of up to £25million for game-changing and commercially viable R&D innovation that can significantly impact the UK economy. This funding is from Innovate UK, part of UK Research and Innovation.
Learn more:
For more information or to apply for the funding opportunity, visit the Innovate UK website today!
Maximum funding available:
up to £6m
Competition closes:
06 January 2022
Funding overview:
Apply for funding to improve the delivery of nucleic acid therapeutics (NAT). One consortium is expected to be funded. Organisations eligible for funding include: small or medium-sized enterprises (SME); academic organisations; public sector organisations. Large businesses cannot request funding. The principal investigator must be UK based. At least one partner must be commercially active in NAT in the UK. The first stage is an expression of interest and you do not need detailed plans or an exact budget to apply.
Learn more:
For more information or to apply for the funding opportunity, visit the UKRI website today!
Maximum funding available:
Not specified.
Competition closes:
11 January 2022
Funding overview:
Apply for funding to support an established research partnership between business and academic institutions. Prosperity partnership programmes must: address EPSRC’s delivery plan priorities, particularly for delivering economic and social prosperity; be business led, but co-created and co-delivered between the industrial and academic partners; support fundamental research with a technology readiness level of one to three. This co-investment opportunity is part of the EPSRC Prosperity Partnerships strategy. The industrial partners must match the funding provided by EPSRC for the partnership. EPSRC will fund: most project costs at 80% full economic cost; studentships at 100% full economic cost.
Learn more:
For more information or to apply for the funding opportunity, visit the UKRI website today!
Maximum funding available:
Up to £300,000
Competition closes:
13 January 2022
Funding overview:
Note: this funding call is anticipated to open on December 06, 2021. Funding is for multi-year research projects. Applications should focus on one or more of the disease areas supported: Chronic Obstructive Pulmonary Disease (COPD), Interstitial lung diseases (ILDs, including idiopathic pulmonary fibrosis and sarcoidosis), Pre-school wheeze.
Learn more:
For more information or to apply for the funding opportunity, visit the BLF website today!
Maximum funding available:
Up to £2m
Competition closes:
26 January 2022
Funding overview:
Please note that the lead applicant must be based in England. The NIHR Invention for Innovation (i4i) Programme is inviting applications for a dementia-specific funding call aimed at the research and development of digital approaches for the early detection, diagnosis and stratification of individuals with dementia. The i4i Programme supports the research and development of innovative medical technologies that have demonstrated proof-of-concept and have a clear developmental pathway towards new products for ultimate NHS use.
Learn more:
For more information or to apply for the funding opportunity, visit the NIHR website today!
Maximum funding available:
Not specified
Competition closes:
31 January 2022
Funding overview:
Every year, health care startups from around the world come to the Texas Medical Center to foster relationships that enable meaningful clinical milestones. Companies are connected with our network of top-tier hospitals and seasoned advisors that will prepare them for clinical validation, funding, and deployment into the world’s largest medical city – the Texas Medical Center.
Learn more:
For more information or to apply for the funding opportunity, visit the TMC website today!
Maximum funding available:
Not specified.
Competition closes:
01 February 2022
Funding overview:
This opportunity provides funding under the European Commission Horizon programme. Note that the call opens from 6th October 2021. This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination 5 “Unlocking the full potential of new tools, technologies and digital solutions for a healthy society”. To that end, proposals under this topic should aim for delivering results that are directed, tailored and contributing to some of the following expected outcomes: Clinical researchers use effective health data integration solutions for the classification of the clinical phenotypes; Researchers and/or health care professionals use robust and validated data-driven computational tools to successfully stratify patients; Regulatory bodies approve computer-aided patient stratification strategies to enable personalised diagnosis and/or personalised therapy strategies; Health care professionals adopt evidence-based guidelines for stratification-based patient management superior to the standard-of-care.
Learn more:
For more information or to apply for the funding opportunity, visit the Horizon website today!
Maximum funding available:
Not specified.
Competition closes:
01 February 2022
Funding overview:
Note that this call is anticipated to open on October 06, 2021. Proposals are expected to develop and test AI tools for assessing and predicting the risk of developing a disease and/or the risk of disease progression once it is diagnosed, taking into account the individuals’ (or groups) genotypes, phenotypes, life-style, occupational/environmental stressors and/or socio-economic and behavioural characteristics, as necessary. Sex and gender aspects should be considered, wherever relevant.
Learn more:
For more information or to apply for the funding opportunity, visit the EU website today!
Maximum funding available:
Not specified.
Competition closes:
01 February 2022
Funding overview:
Note that this call is anticipated to open on October 06, 2021. Proposals should aim to diversify and accelerate the global vaccine research and development pipeline, and to strengthen the current leading role of the EU in vaccine research and development. Proposals should cover those pathogens, which still lack vaccines of sufficient efficacy, but where earlier efforts have already produced promising vaccine candidates.
Learn more:
For more information or to apply for the funding opportunity, visit the EU website today!
Maximum funding available:
Not specified.
Competition closes:
01 February 2022
Funding overview:
Note that this call is anticipated to open on October 06, 2021. Immunotherapy is defined as a treatment able to stimulate or restore the ability of the immune (defence) system to fight infection, disease or disorder. It has proved to be a valuable medical treatment notably when preventive interventions are not available. Passive and active immunotherapies (such as antibody-based, RNA-based and cell-based therapies, respectively) are covered by this topic, which is aiming at the pre-clinical to first-in human development of next generation immunotherapies for unmet needs. Proposals should build on existing knowledge in the field, when available, in order to save time and to avoid spilling resources, and could build on the knowledge of the interaction between the immune system (innate and adaptive arms) and the microbiota, or take advantage of key enabling technologies such as biotechnology and nanotechnology, advanced manufacturing, imaging, 5G, internet of things, artificial intelligence and existing databases.
Learn more:
For more information or to apply for the funding opportunity, visit the EU website today!
Maximum funding available:
up to $100,000
Competition closes:
04 February 2022
Funding overview:
We are proud to continue the Johnson & Johnson Nurses Innovate QuickFire Challenge series with an eighth Nurses Innovate QuickFire Challenge together with the American Nursing Informatics Association (ANIA) and the American Organization for Nursing Leadership (AONL). Focused on “Healthcare Transformation Through Nurse-led Tech,” we look to nurses to create technology-based potential solutions that aim to drive healthcare transformation, enhance the patient experience, improve the health of populations, reduce per capita costs, and enhance the caregiver experience amid the current pandemic environment and beyond.
The nurse innovators with the best idea(s) will receive up to $100,000 in grant funding and access to mentoring from experts across the Johnson & Johnson Family of Companies to help bring their ideas to life.
Learn more:
For more information or to apply for the funding opportunity, visit the Johnson & Johnson website today!
Maximum funding available:
Up to £80,000
Competition closes:
10 February 2022
Funding overview:
High-risk grants to encourage novel ideas. Applications should focus on one or more of Chronic Obstructive Pulmonary Disease (COPD), Interstitial lung diseases (ILDs, including idiopathic pulmonary fibrosis and sarcoidosis), Pre-school wheeze.
Learn more:
For more information or to apply for the funding opportunity, visit the BLF website today!
Maximum funding available:
Proportionate according to project need, criteria and impact.
Competition closes:
15 February 2022
Funding overview:
The Planned Care Innovation Programme will fund and support innovative projects from across the spectrum of health and social care (including the voluntary sector and community groups) in Wales to develop, apply and test new ways of working, which (and/or): Have potential to positively transform or impact planned care pathways in Wales; Aim to reduce or alleviate the demand on planned care services in Wales.
Learn more:
For more information or to apply for the funding opportunity, visit the Bevan Commission website today!
Maximum funding available:
£30,000
Competition closes:
23 February 2022
Funding overview:
Brought to you by Blockchain Connected and fully-funded by the Welsh Government, this Challenge will provide an opportunity to explore the art of the possible, raising the awareness of blockchain’s potential to solve key challenges for both private & public sector organisations.
Learn more:
For more information or to apply for the funding opportunity, visit the Blockchain website today!
Maximum funding available:
£50,000
Competition closes:
28 February 2022
Funding overview:
This ophthalmology-focused open call grant is open to all UKEGS members.
Learn more:
For more information or to apply for the funding opportunity, visit the Glaucoma UK website today!
Maximum funding available:
Up to £100,000
Competition closes:
01 March 2022
Funding overview:
Apply for funding to research environmental sustainability in life science and medical practice.
Learn more:
For more information or to apply for the funding opportunity, visit the UKRI website today!
Maximum funding available:
Up to £30,000
Competition closes:
04 March 2022
Funding overview:
The Innovation to Commercialisation of University Research (ICURe) Programme is a collaboration between SETsquared, NorthbyNorthwest Partnership, Midlands Partnership, Innovate UK, UK Research & Innovation (UKRI) and Department for Business, Energy and Industrial Strategy (BEIS) and is designed to move ideas and innovation out of labs and into the marketplace where they will have the greatest impact.
Learn more:
For more information or to apply for the funding opportunity, visit the ICURe website today!
Maximum funding available:
£250,000
Competition closes:
08 March 2022
Funding overview:
Note: this funding call is anticipated to open on January 11, 2022. Apply for funding to develop or improve drugs or plant protection agents to help: treat bacterial or fungal infections; reduce the spread of resistance to drugs.
Learn more:
For more information or to apply for the funding opportunity, visit the UKRI website today!
Maximum funding available:
up to 80% of £500,000
Competition closes:
08 March 2022
Funding overview:
Apply for a fellowship to explore your own research ideas and develop links with industry, including secondments, training and mentorship. Your research project should support the development of cell and oligonucleotide therapies. You must have: a PhD, or equivalent higher research degree, by the start of the fellowship; the support of a research organisation eligible for MRC funding. This opportunity is open to both clinical and non-clinical researchers. You should be in the early stage of your postdoctoral career. The full economic cost of your fellowship can be up to £500,000. MRC will fund 80% of the full economic cost. You will be funded for three years.
Learn more:
For more information or to apply for the funding opportunity, visit the UKRI website today!
Maximum funding available:
Up to £100,000
Competition closes:
10 March 2022
Funding overview:
Supports researchers at all stages to develop early, novel and outside-the-box ideas and collaborations to build and make progress in the ED&D field.
Learn more:
For more information or to apply for the funding opportunity, visit the Cancer Research UK website today!
Maximum funding available:
Up to £750,000
Competition closes:
14 March 2022
Funding overview:
Translational Awards aim to progress the development of novel, innovative technologies towards benefits to human cardiovascular health.
Learn more:
For more information or to apply for the funding opportunity, visit the BHF website today!
Maximum funding available:
No limit (£10m available every year)
Competition closes:
16 March 2022
Funding overview:
Please note that this is a planned call due to open on 19/01/2022.Apply for MRC funding to investigate the causes, progression and treatment of human disease. Your project must: include an experimental intervention or challenge in humans; focus on a mechanistic hypothesis; be academically-led. You must be based at an eligible research organisation. There is no limit to the amount of funding you can apply for or the length of your project.
Learn more:
For more information or to apply for the funding opportunity, visit the UKRI website today!
Maximum funding available:
Up to £2.5m
Competition closes:
24 March 2022
Funding overview:
Funds long-term, integrated and renewable programmes of exceptional science to transform how and when early cancers and pre-cancerous states are diagnosed.
Learn more:
For more information or to apply for the funding opportunity, visit the Cancer Research UK website today!
Maximum funding available:
Not specified
Competition closes:
24 March 2022
Funding overview:
This scheme provides funding for established researchers and teams from any discipline who want to pursue bold and creative research ideas to deliver significant shifts in understanding that could improve human life, health and wellbeing.
Learn more:
For more information or to apply for the funding opportunity, visit the Wellcome Trust website today!
Maximum funding available:
No limit
Competition closes:
31 March 2022
Funding overview:
Your application should be in line with the grand challenges of the EPSRC healthcare technologies theme.
Learn more:
For more information or to apply for the funding opportunity, visit the UKRI website today!
Maximum funding available:
£100,000
Competition closes:
31 March 2022
Funding overview:
This grant is open to medical and non-medical professionals, and we are particularly keen to hear from optometrists, orthoptists, nurses and allied healthcare professionals.
Learn more:
For more information or to apply for the funding opportunity, visit the Glaucoma UK website today!
Maximum funding available:
Dependent on Call
Competition closes:
April 2022
Funding overview:
Horizon Europe has a wide variety of open calls for healthcare, with closing dates in September 2021, April 2022 and September 2022. These include tackling diseases and reducing disease burden, staying healthy, health industry, health care, new technologies and digital solutions for a healthy society, and health-promoting environment.
Learn more:
For more information or to apply for the funding opportunity, visit the KTN UK website today!
Maximum funding available:
No limit
Competition closes:
06 April 2022
Funding overview:
Note: this funding call is anticipated to open on February 11, 2022. Apply for funding to help you become an internationally recognised research leader in your field. Your research can focus on any area of MRC’s remit to improve human health.
Learn more:
For more information or to apply for the funding opportunity, visit the UKRI website today!
Maximum funding available:
Not specified
Competition closes:
21 April 2022
Funding overview:
This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of “Maintaining an innovative, sustainable and globally competitive health industry”.
Learn more:
For more information or to apply for the funding opportunity, visit the EU website today!
Maximum funding available:
Not specified
Competition closes:
21 April 2022
Funding overview:
This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of “Staying healthy in a rapidly changing society”.
Learn more:
For more information or to apply for the funding opportunity, visit the EU website today!
Maximum funding available:
Not specified
Competition closes:
21 April 2022
Funding overview:
This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of “Unlocking the full potential of new tools, technologies and digital solutions for a healthy society”.
Learn more:
For more information or to apply for the funding opportunity, visit the EU website today!
Maximum funding available:
Not specified
Competition closes:
04 May 2022
Funding overview:
Note: this funding call is anticipated to open on February 16, 2022. Apply for a grant to support new partnerships between diverse groups of researchers in molecular and cellular medicine. You must be based at a UK research organisation eligible for MRC funding. This includes MRC units and centres.
Learn more:
For more information or to apply for the funding opportunity, visit the UKRI website today!
Maximum funding available:
£60,000
Competition closes:
15 May 2022
Funding overview:
Funding is provided for research as a main priority. Studies should consider the effect of diet and/or the microbiome on neurodevelopmental disorders.
Learn more:
For more information or to apply for the funding opportunity, visit the Waterloo Foundation website today!
Maximum funding available:
Not specified
Competition closes:
18 May 2022
Funding overview:
Note: this funding call is anticipated to open on February 16, 2022. Apply for a grant to support new partnerships between diverse groups of researchers in population and systems medicine. You must be based at a UK research organisation eligible for MRC funding. This includes MRC units and centres.
Learn more:
For more information or to apply for the funding opportunity, visit the UKRI website today!
Maximum funding available:
£50,000
Competition closes:
22 May 2022
Funding overview:
This grant is open to medical and non-medical professionals, and we are particularly keen to hear from optometrists, orthoptists, nurses and allied healthcare professionals.
Learn more:
For more information or to apply for the funding opportunity, visit the Glaucoma UK website today!
Maximum funding available:
No limit
Competition closes:
25 May 2022
Funding overview:
Note: this funding call is anticipated to open on February 16, 2022. Apply for funding for a programme of research focused on neurosciences and mental health. You must be based at a UK research organisation eligible for MRC funding. This includes MRC units and centres.
Learn more:
For more information or to apply for the funding opportunity, visit the UKRI website today!
Maximum funding available:
Salary + up to £20,000 pa
Competition closes:
06 July 2022
Funding overview:
Note: this funding call is anticipated to open in April, 2022. Alzheimer’s Research UK Clinical Research Fellowships are designed for promising clinically qualified researchers who have delivered previous research projects with evidence of impactful outputs and have clear plans to establish their own research ‘niche’.
Learn more:
For more information or to apply for the funding opportunity, visit the ARUK website today!
Maximum funding available:
Not specified
Competition closes:
21 September 2022
Funding overview:
The topic is to support the research infrastructure implementation and enrichment to ensure the delivery of a cloud-based wide-range of integrated facilities and distributed specialised competence centres, for comprehensively serving the European communities for neuroscience and research in brain medicine, including for dementia and other neurodegenerative conditions, and brain-inspired cognitive technologies.
Learn more:
For more information or to apply for the funding opportunity, visit the EU website today!
Maximum funding available:
Not specified
Competition closes:
30 September 2022
Funding overview:
This Open Call for Proposals is aimed at fostering activities bringing space technology that contributes towards shaping the NHS Future Hospital project initiative, recently kicked off by the Hampshire Hospitals NHS Foundation Trust.
Learn more:
For more information or to apply for the funding opportunity, visit the ESA website today!
Maximum funding available:
Not specified
Competition closes:
Competition remains open
Funding overview:
Out of the original City Deal funding, £495m has been allocated to a Wider Investment Fund. This is the primary fund that proposals that align with the 3 priority investment areas of Innovation, Infrastructure and Challenge should access. Cardiff Capital Region are seeking proposals into this fund that have the scale and ambition to radically address the challenges facing the region.
Learn more:
For more information or to apply for the funding opportunity, visit the CCR website today!
Maximum funding available:
£10,000,000
Competition closes:
No closing date
Funding overview:
Flexible business finance for companies based in Wales going from £1,000 up to £10 million. Loans and equity. Secured and unsecured.
Learn more:
For more information or to apply for the funding opportunity, visit the Development Bank of Wales website today!
Maximum funding available:
€ 2,500,000
Competition closes:
No closing date
Funding overview:
The EIC Accelerator supports individual Small and Medium Enterprises (SMEs), in particular Startups and spinout companies to develop and scaleup game-changing innovations. In some cases small mid-caps (up to 500 employees) are supported.
Learn more:
For more information or to apply for the funding opportunity, visit the European Innovation Council website today!
Maximum funding available:
£80,000
Competition closes:
No closing date
Funding overview:
Apply for funding to support short-term time-sensitive collection of data or samples or rapid turn-around research or analysis to either:
Please note, this is a rarely awarded emergency route for exceptional circumstances.
Learn more:
For more information or to apply for the funding opportunity, visit the UKRI website today!
Maximum funding available:
No limit
Competition closes:
No closing date
Funding overview:
This UK-wide programme will deliver £375m of government funding via British Patient Capital, a commercial subsidiary of the British Business Bank. Due to high research and development costs, breakthrough technology companies typically require more capital than other companies, to fuel the later stages of their growth. Operates on a commercial basis with private sector investors to co-invest with British Patient Capital.
Learn more:
For more information or to apply for the funding opportunity, visit the Future Fund website today!
Maximum funding available:
No limit
Competition closes:
Competition remains open
Funding overview:
Providing funding to organisations who share our special purpose to help people do more, feel better, and live longer. GSK provides financial support to organizations that: Foster an increased understanding of scientific, clinical, healthcare, and community issues; Have a general interest in progressing the prevention, treatment, and management of disease; Contribute to improving patient care and quality of life.
Learn more:
For more information or to apply for the funding opportunity, visit the GSK website today!
Maximum funding available:
80% of project costs
Competition closes:
No closing date
Funding overview:
Healthcare technologies investigator-led research grants are for researchers at UK higher education institutions, research council institutes, UKRI-approved independent research organisations and NHS bodies. The funder strongly encourage collaboration with relevant healthcare professionals, other researchers, industry, the public sector and other relevant partners. Your application should be in line with the grand challenges of UKRI's healthcare technologies theme.
Learn more:
For more information or to apply for the funding opportunity, visit the UKRI website today!
Maximum funding available:
up to £62,500
Competition closes:
Competition remains open
Funding overview:
Since the first call for the Healthy Ageing Catalyst Awards in 2020, Zinc and UKRI have partnered to fund entrepreneurial academics who want to translate their research into impactful and scalable products, services and interventions. The Awards are part of the UKRI Healthy Ageing Challenge and the Healthy Longevity Global Grand Challenge, founded by the U.S. National Academy of Medicine. This is a worldwide movement to improve physical, mental, and social well-being for people as they age. In 2022, Zinc will support its third cohort of researchers to create innovations that: Allow everyone to remain active, productive, independent and socially connected across generations for as long as possible; Narrow the gap between the experiences of the richest and the poorest.
Learn more:
For more information or to apply for the funding opportunity, visit the Zinc website today!
Maximum funding available:
No limit
Competition closes:
No closing date
Funding overview:
HSBC UK has announced a £14 billion lending fund to support the UK’s small and medium-sized enterprises (SMEs). The Fund includes a ring-fenced £1 billion to help UK companies grow their business overseas, as well as a broader package of support. The initiative is available to UK businesses with a turnover of up to £350 million. Applicants do not need to be an HSBC customer to apply.
Learn more:
For more information or to apply for the funding opportunity, visit the HSBC website today!
Maximum funding available:
£7,500
Competition closes:
No closing date
Funding overview:
The MedTech NAVIGATOR Innovation Grants are designed to facilitate such bespoke interactions between SMEs and eligible Knowledge Providers, such as an NHS Trust, or a University, during the product development process. Each Innovation Grant (up to £7,500) is worth 50% of the total project costs up to a maximum of £15,000. Your business must pay the remaining 50% and any project costs over and above the £15,000 cap.
Learn more:
For more information or to apply for the funding opportunity, visit the MedTech Navigator website today!
Maximum funding available:
No limit
Competition closes:
No closing date
Funding overview:
The Moondance Cancer Initiative fund projects that innovate and improve the collective response to cancer in Wales so that more people survive. They welcome applications at any time for projects with a measurable potential impact on cancer survival outome and have a particular interest in projects that impact bowel cancer and upper gastro-intestinal cancer survival.
Learn more:
For more information or to apply for the funding opportunity, visit the Moondance Cancer Initiative website today!
Maximum funding available:
£10,001 to £500,000
Competition closes:
Competition remains open
Funding overview:
People and Places: Large grants offers funding from £10,001 to £500,000 for projects where people and communities are working together and using their strengths to make positive impacts on the things that matter to them the most. We are prioritising projects that are:
Although we are supporting responses to the pandemic, your project does not have to be directly related to COVID-19 to be funded.
Learn more:
For more information or to apply for the funding opportunity, visit the The National Lottery website today!
